Targeted disruption of transcriptional regulatory function of p53 by a novel efficient method for introducing a decoy oligonucleotide into nuclei

Nucleic Acids Research

Volumn 33, Issue 9, 2005, Pages 1-9

  Sakaguchi, Masakiyo ^a   Nukui, Takamasa ^a   Sonegawa, Hiroyuki ^a   Murata, Hitoshi ^b   Futami, Junichiro ^b   Yamada, Hidenori ^b   Huh, Nam Ho ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CISPLATIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; GLUTATHIONE TRANSFERASE; GLYCINE; OLIGONUCLEOTIDE; PROTEIN BAX; PROTEIN P53; TRANSCRIPTION FACTOR GAL4; CARRIER PROTEIN;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DNA FLANKING REGION; DNA RESPONSIVE ELEMENT; EMBRYONIC STEM CELL; HUMAN; HUMAN CELL; MOUSE; NERVE CELL CULTURE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ACTIVE TRANSPORT; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; METABOLISM; PROTEIN ENGINEERING; TRANSACTIVATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CARRIER PROTEINS; CELL NUCLEUS; CELLS, CULTURED; HUMANS; MICE; NUCLEAR LOCALIZATION SIGNALS; OLIGONUCLEOTIDES; PROTEIN ENGINEERING; RATS; RESPONSE ELEMENTS; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 27244436612     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gni088     Document Type: Article

References (37)

1. Wall, N.R. and Shi, Y. (2003) Small RNA: Can RNA interference be exploited for therapy. Lancet, 362, 1401-1403.
2. Scanlon, K.J. (2001) Anti-genes: SiRNA, ribozymes and antisense. Curr. Pharm. Biotechnol., 5, 415-420.
3. Mann, M.J., and Dzau, V.J. (2000) Therapeutic applications of transcription factor decoy oligonucleotides. J. Clin. Invest., 106, 1071-1075.
4. Morishita, R., Tomita, N., Kaneda, Y. and Ogihara, T. (2004) Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Curr. Opin. Pharmacol., 4, 139-146.
5. Isner, J.M. (1997) Oligonucleotide therapeutics - novel cardiovascular targets. Nature Med., 3, 834-835.
6. Cho-Chung, Y.S., Park, Y.G. and Lee, Y.N. (1999) Oligonucleotides as transcription factor decoys. Curr. Opin. Mol. Ther., 1, 380-392.
7. Bielinska, A., Shivdasani, R.A., Zhang, L.Q., and Nabel, G.J. (1990) Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. Science, 250, 997-1000.
8. Sullenger, B.A., Gallardo, H.F., Ungers, G.E. and Gilboa, E. (1990) Overexpression of TAR sequences renders cells resistant to human immunodefeciency virus replication. Cell, 63, 601-608.
9. Yamada, T., Horiuchi, M., Moroshita, R., Zhang, L., Pratt, R.E. and Dzan, V.J. (1995) In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J. Clin. Invest., 96, 1230-1237.
10. Morishita, R., Gibbons, G.H., Horiuchi, M., Ellison, K.E., Nakama, M., Zhang, L., Kaneda, Y., Ogihara, T. and Dzau, V.J. (1995) A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl Acad. Sci. USA, 92, 5855-5859.
11. Morishita, R., Sugimoto, T., Aoki, M., Kida, I., Tomita, N., Moriguchi, A., Maeda, K., Sawa, Y., Kaneda, Y., Higaki, J. et al. (1997) In vivo transfection of cis element 'decoy' against nuclear-factor-kappaB binding site prevents myocardial infarction. Nature Med., 3, 894-899.
12. Morishita, R., Gibbons, G.H., Horiuchi, M.. Kaneda, Y., Ogihara, T. and Dzau, V.J. (1998) Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: Using, decoy, approach against AP-1 binding site. Biochem. Biophys. Res. Commun.. 243, 361-367.
13. Park, Y.G., Nesterova, M.. Agrawal, S. and Cho-Chung, Y.S. (1999) Dual blockade of cyclic AMP response element- (CRE) and AP-1-directed transcription by CRE-transcription factor decoy oligonucleotide. Gene specific inhibition of tumor growth. J. Biol. Chem., 274, 1573-1580.
14. Khaled, A.R., Butfiloski, E.J., Sobel, E.S. and Schiffenbauer, J. (1998) Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-kappaB expression and lymphocyte function. Clin. Immunol. Immunopathol., 86, 170-174.
15. Crinelli, R., Bianchi, M., Gentilini, L. and Magnani, M. (2002) Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res., 30, 2435-2443.
16. Ahn, J.D., Morishita, R., Kaneda, Y., Lee, S.J., Kwon, K.Y., Choi, S.Y., Lee, K.U.. Park, J.Y., Moon, I,J. Park, J.G. et al. (2002) Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo. Circ. Res., 90, 1325-1332.
17. Bene, A., Kurten, R.C. and Chambers, T.C. (2004) Subcellular localization as a limiting factor for utilization of decoy oligonucleotides. Nucleic Acids Res., 32, e142.
18. Griesenbach, U., Cassady, R.L., Cain, R.J., du Bois, R.M., Geddes, D.M. and Alton, E.W. (2002) Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation. Gene Ther., 9, 1109-1115.
19. Meyer, N.. Jaconi, M., Landopoulou, A., Fort, P. and Puceat, M. (2000) A fluorescent reporter gene its a marker for ventricular specification in ES-derived cardiac cells. FEBS Lett., 478, 151-158.
20. Miyazaki, M., Handa, Y., Oda, M., Yabe, T., Miyano, K. and Sato, J. (1985) Long-term survival of functional hepatocytes from adult rat in the presence of phenobarbital in primary culture. Exp. Cell. Res., 159, 176-190.
21. 2+ ionophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res., 652, 65-70.
22. Sadowski, I.. Bell, B., Broad, P. and Hollis, M. (1992) GAL4 fusion vectors for expression in yeast or mammalian cells. Gene, 118, 131-141.
23. Yoneda, Y., Semba, T., Kaneda, Y., Noble, R.L., Matsuoka, Y., Kurihara, T., Okada, Y. and Imamoto, N. (1992) A long synthetic peptide containing a nuclear localization signal and its flanking sequences of SV40 T-antigen directs the transport of IgM into the nucleus efficiently. Exp. Cell. Res., 201, 313-320.
24. Giniger, E., Varnum, S.M. and Ptashne, M. (1985) Specific DNA binding of GAL4, a positive regulatory protein of yeast. Cell, 40, 767-774.
25. Nakano, K., Mizuno, T., Sowa, Y., Orita, T., Yoshino, T., Okuyama, Y., Fujita, T., Ohtani-Fujita, N., Matsukawa, Y., Tokino, T. et al. (1997) Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem., 272, 22199-22206.
26. Takahashi, Y., Rayman, J.B. and Dynlacht, B.D. (2000) Analysis of promoter binding by tile E2F and pRB families in vivo: Distinct E2F proteins mediate activation and repression. Genes Dev., 14, 804-816.
27. Mitchell, D.J., Kim, D.T.. Steinman, L., Fathman, C.G. and Rothbard, J.B., (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers J. Pept. Res., 56, 518-325.
28. Matsushita, M., Tomizawa, K., Moriwaki, A., Li, S.T., Terada, H. and Matsui, H. (2001) A high-efficiency protein transduction system demonstrating, the role of PKA in long-lasting long-term potentiation. J. Neurosci., 21, 6000-6007.
29. Fan, S., el-Deiry, W.S., Bae, I., Freeman, J., Jondle, D., Bhatia, K., Fornace, A.J. Jr, Magrath, I., Kohn, K.W. and O'Connor, P.M. (1994) p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res., 54, 5824-5830.
30. Perego, P.. Giarola, M., Righetti, S,C., Supino, F., Caserini, C., Delia, D., Pierotti, M.A., Miyashita, T., Reed, J.C. and Zunino, F. (1996) Association between cisplatia resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell system. Cancer Res., 56, 556-562.
31. Namiki, S., Tomida, T., Tanabe, M., Iino, M. and Hirose, K. (2003) Intracellular delivery of glutathione S-transferase into mammalian cells. Biochem. Biophys. Res. Commun., 305, 592-597.
32. Nigahara, H. Vocero-Akbani, A.M., Snyder, E.L., Ho, A., Latham, D.G., Lissy, N.A., Becker-Hapak, M., Ezhevsky, S.A. and Dowdy, S.F. (1998) Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nature Med., 4, 1449-1452.
33. Sakaguchi, M., Miyazaki, M.. Takaishi, M., Sakaguchi, Y., Makino, E.. Kataoka, N., Yamada, H., Namba, M. and Huh, N.H. (2003) S100C/A11 is a key mediator of Ca(2+)-induced growth inhibition of human epidermal keratinocytes. J. Cell. Biol., 163, 825-835.
34. Futami, J., Kitazoe, M., Maeda, T., Nukui, E., Sakaguchi, M., Kosaka, J., Miyazaki, M., Kosaka, M., Tada, H., Seno, M. et al. (2005) Intracellular delivery of proteins into mammalian living cells by polyethyleniminecationization. J. Biosci. Bioeng., 99, 95-103.
35. Friedman, P.N., Chen, X., Bargonetti, J. and Prives, C. (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc. Natl Acad. Sci. USA, 90, 3319-3323.
36. Chan, W.M., Siu, W.Y., Lau, A. and Poon, R.Y. (2004) How many mutant p53 molecules are needed to inactivate a tetramer? Mol. Cell. Biol., 24, 3516-3551.
37. Filippini, G., Griffin, S., Uhr, M., Eppenberger, H., Bonilla, J., Cavalli, F. and Soldati, G. (1998) A novel flow cytometric method for the quantification of p53 gene expression. Cytometry, 31, 180-186.